KALA BIO
KALA
113 hedge funds and large institutions have $452M invested in KALA BIO in 2020 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 40 increasing their positions, 20 reducing their positions, and 14 closing their positions.
214% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 14
100% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 20
40% more call options, than puts
Call options by funds: $3.71M | Put options by funds: $2.65M
36% more funds holding
Funds holding: 83 → 113 (+30)
28% more capital invested
Capital invested by funds: $353M → $452M (+$98.2M)
0% more ownership
Funds ownership: 0.03% → 0.03% (+0%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$20.7M |
| 2 |
BlackRock
New York
|
+$14M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$5.64M |
| 4 |
Citigroup
New York
|
+$4.87M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$4.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Caxton Corporation
Princeton,
New Jersey
|
-$13.8M |
| 2 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$6.88M |
| 3 |
BBVA
Banco Bilbao Vizcaya Argentaria
Madrid,
Spain
|
-$6.85M |
| 4 |
Millennium Management
New York
|
-$5.5M |
| 5 |
PVMCV
Polaris Venture Management Co V
Boston,
Massachusetts
|
-$4.97M |
KALA Hedge Fund Activity: Q2 2020 in Review
113 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q2 2020, worth a combined $452M — up 28% from $353M a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new KALA positions and 14 closed out — a net gain of 30 holders — while 40 added to existing stakes and 20 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $20.7M. The largest seller was Caxton Corporation, cutting an estimated $13.8M.
- 113 institutional investors held KALA BIO (KALA) as of Q2 2020, up from 83 in Q1 2020.
- Funds reported $452M of KALA BIO stock for Q2 2020, up 28% quarter-over-quarter.
- 44 funds opened new KALA BIO positions in Q2 2020 and 14 closed out, a net change of +30 holders.
- The largest KALA BIO buyer in Q2 2020 was Fidelity Investments, an estimated $20.7M added.
- The largest KALA BIO seller in Q2 2020 was Caxton Corporation, an estimated $13.8M sold.
Based on aggregated 13F filings for Q2 2020.